Overview

Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The objectives of this survey was to retrospectively collect and evaluate the information on the efficacy and safety of PAXIL tablets ("PAXIL", hereinafter) in pediatric subjects (aged under 18) with panic disorder under conditions of actual use.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Paroxetine